Key opportunities in the animal vaccines market include addressing livestock disease outbreaks, leveraging next-gen mRNA technology, and reinforcing the One Health approach for zoonotic prevention. With rising global trade demands, biosecurity and advanced va…
Key market opportunities in the Ebola virus vaccine sector include advancements in mRNA technology, demand for immunization in outbreak-prone regions, and collaboration between pharmaceutical firms, governments, and NGOs. Challenges in distribution logistics …
U.S. Personalized Cancer Vaccine Market was valued at USD 76.8 million in 2025 and is expected to reach USD 2.743 billion by 2035 owing to the presence of most prominent personalized vaccine manufacturers U.S. Personalized Cancer Vaccine Market was valued at …